SEC Form 4 · accession 0001127602-16-044024

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman, President and CEO · Director

Period of report

Feb 26, 2016

Accepted (ET)

Mar 1, 2016 · 7:51 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Feb 26, 2016	A	20,478	$0.00	A	388,334	D
Common Stock	Feb 27, 2016	F	2,301	$73.70	D	386,033	D
Common Stock	Feb 28, 2016	F	2,397	$73.70	D	383,636	D
Common Stock	holding	—	—		—	340	I	By Trust
Common Stock	holding	—	—		—	10,000	I	Held By Spouse

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options (Right to Buy)^F2	$73.70	Feb 26, 2016	A	100,494	A	Feb 26, 2017	Feb 26, 2021	Common Stock	100,494	100,494	D

F1Consists of 20,478 unvested restricted stock units that vest as follows: 5,119 shares vest one (1) year from the date of issuance, 5,120 shares vest two (2) years from the date of issuance, 5,119 shares vest three (3) years from the date of issuance, and 5,120 shares vest four (4) years from the date of issuance.
F2Stock options vest as follows: 25,123 options vest one (1) year from the date of grant, 25,124 options vest two (2) years from the date of grant, 25,123 options vest three (3) years from the date of grant, and 25,124 options vest four (4) years from the date of grant.